Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).

Fiche publication


Date publication

février 2023

Journal

Hepatology (Baltimore, Md.)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PETIT Jean-Michel


Tous les auteurs :
Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L

Résumé

The severity of liver injury and clinical outcomes in lean NAFLD subjects is a subject of debate and very few studies have been performed in the general population. The aim of this study was to compare subject characteristics and mortality between lean and non-lean NAFLD in a community setting.

Référence

Hepatology. 2023 02 24;: